The GLP is committed to full transparency. Download and review our 2019 Annual Report

Japanese researchers gain approval for ‘basic research’ on gene-edited human embryos

4-30-2019 embryo x
A pipette injects CRISPR-Cas9 gene-editing tools into a mouse embryo. Image: University of Utah Health Sciences
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A government research panel specializing in life ethics approved the modification of genes from fertilized human eggs for basic research to treat genetic diseases.

As of now, however, the panel will not allow births with gene-modified fertilized eggs due to safety and ethical considerations.

The panel’s decision will pave the way for research that could start in spring next year at the earliest into ways to correct genetic defects.

Genome editing to repair gene abnormalities in fertilized eggs is aimed at preventing genetic defects from being passed down through generations.

At least 12 cases are known in the United States, China and elsewhere, where genome editing was done on fertilized eggs. In about half of the cases, the intention was to prevent intractable and other diseases.

Related article:  Families plagued by inherited diseases push back against ban on gene-edited embryos

“People will welcome genome editing of fertilized eggs if it prevents genetic diseases,” said an expert who took part in the research panel’s discussions. “Basic research must be carried out. Otherwise, there is little possibility of being able to alter genes with total accuracy.”

If the research reaches the stage of practical use, regulating gene manipulation will likely prove to be the next big hurdle.

Read full, original post: Panel permits gene editing using fertilized human eggs

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend